September 2023 - Saturn Partners

Biohaven Reports Positive Data From EEG Biomarker Study Of BHV-7000

Posted on September 5, 2023 at 8:47 am.

(RTTNews) – Clinical-stage biopharmaceutical company Biohaven Ltd. (BHVN) Tuesday announced positive biomarker data from the Phase 1 electroencephalogram (EEG) biomarker study of its lead asset BHV-7000, proposed for the treatment of epilepsy. Examination of EEG in healthy subjects administered single … Continued

Agri-Nutrients SABIC cooperates with American companies to support sustainable farming

Posted on September 1, 2023 at 8:33 am.

Written by saturnadmin

Through these collaborative efforts, SABIC aims to help reduce the carbon footprint in the agricultural supply chain, especially after the company obtained the world’s first independent certifications for low-carbon ammonia and blue hydrogen from TÜV Rheinland Group Riyadh: Agri-Nutrients SABIC, … Continued

Monthly Archives: September 2023